BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22646247)

  • 1. Primary sclerosing cholangitis: providing a safe and effective treatment.
    Imam MH; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):255-7. PubMed ID: 22646247
    [No Abstract]   [Full Text] [Related]  

  • 2. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and medical therapy of primary sclerosing cholangitis.
    van Milligen de Wit AW
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 9. A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
    Suskind DL; Finn L; Wahbeh G; Christie D; Horslen S
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):542-4. PubMed ID: 17033534
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
    Wolf JM; Rybicki LA; Lashner BA
    Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
    Serfaty L; Poupon R
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
    [No Abstract]   [Full Text] [Related]  

  • 12. Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy.
    Fong DG; Lindor KD
    Am J Gastroenterol; 2000 Aug; 95(8):1861-2. PubMed ID: 10950026
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
    Leftwich H; Fang YM; Borgida A; Crombleholme W
    J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
    Zimmer V; Lammert F
    EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.
    Chapman RW
    Dig Liver Dis; 2003 May; 35(5):306-8. PubMed ID: 12846401
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
    MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case.
    Kita Y; Lake JR; Ferrell LD; Mori M; Roberts JP; Kakizoe S; Kiyosawa K; Tanaka E; Shiga J; Takikawa H; Inoue Y; Ohtake T; Ohtomo K; Yotsuyanagi H; Oka T; Harihara Y; Takayama T; Kubota K; Kawarasaki H; Hashikura Y; Kawasaki S; Ascher NL; Makuuchi M
    Transplant Proc; 1998 Nov; 30(7):3321-3. PubMed ID: 9838468
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical and endoscopic therapy of primary sclerosing cholangitis.
    Weismüller TJ; Lankisch TO
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):741-52. PubMed ID: 22117639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.